# IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy

> clinical trial · VERIFIED · 2026-07-15

Status: NOT_YET_RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Recurrent Prostate Cancer

- Company: National Cancer Institute (NCI)
- Sector: Recurrent Prostate Cancer
- Primary source: https://clinicaltrials.gov/study/NCT07686380

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.